Simultaneous Detection of Protein and RNA Using Proximity Ligation of Aptamers and Quantitative Polymerase Chain Reaction

10 June 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The COVID-19 pandemic underscored the global need for rapid, sensitive, and multiplexed diagnostic assays for viral detection. RT-qPCR remains the standard for SARS-CoV-2 RNA detection, while antigen-based protein assays provide faster, though less sensitive, alternatives. Here, we present a novel diagnostic platform that combines proximity ligation of aptamers (PLA) with real-time quantitative PCR (RT-qPCR) to enable simultaneous detection of both SARS-CoV-2 RNA and nucleocapsid (N) protein in a single vial. Six high-affinity aptamers against the N protein were identified via capillary electrophoresis SELEX. From these, ECK1 and ECK4 were selected based on binding affinity and spatial compatibility for PLA. The aptamer pair enabled target-induced ligation followed by detection using Cy5-labeled TaqMan probes. Concurrently, SARS-CoV-2 RNA was detected with FAM-labeled probes in the same RT-qPCR reaction. This dual-analyte assay was validated in buffer and complex biological matrices such as saliva. Sensitivity was further enhanced by integrating droplet digital PCR (ddPCR). Aptamer binding sites at the N protein were identified via DEPC labeling and bottom-up proteomics. Our method introduces a scalable and adaptable strategy for multiplexed pathogen diagnostics with minimal sample processing.

Keywords

Aptamers
Proximity Ligation Assay (PLA)
RT-qPCR
SARS-CoV-2
biolayer interferometry (BLI)
Multiplex Diagnostics
ddPCR
CE SELEX
Viral Detection
TaqMan Probes
Protein-RNA Co-detection

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.